Targeted chemotherapy against intraperitoneally disseminated colon carcinoma using a cationized gelatin-conjugated HVJ envelope vector

Molecular Cancer Therapeutics
Hidetoshi MimaYasufumi Kaneda

Abstract

The hemagglutinating virus of Japan envelope (HVJ-E; Sendai virus) vector derived from inactivated HVJ particles can be used to deliver DNA, proteins, and drugs into cells both in vitro and in vivo. HVJ-E is capable of delivering bleomycin, an anticancer drug, to various cancer cell lines, thereby producing 300-fold greater cytotoxicity than administration of bleomycin alone. In a mouse model of peritoneally disseminated colon cancer, we injected HVJ-E containing the luciferase gene into the peritoneum. Unexpectedly, luciferase gene expression was not observed within the tumor deposits or any organs. However, when combined with cationized gelatin (CG), CG-HVJ-E produced a high level of luciferase gene expression primarily within the tumor deposits. Forty-eight hours after introducing colon cancer cells into the peritoneum of experimental mice, CG-HVJ-E with or without bleomycin was injected into the abdominal cavity. Following six injections of bleomycin-incorporated CG-HVJ-E, complete responses were observed in 40% of the mice examined. All of the mice that received either empty CG-HVJ-E or bleomycin alone died within 40 days of having cancer cells introduced into the peritoneum. When the mice with complete responses were rech...Continue Reading

References

Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·E WagnerM L Birnstiel
Apr 1, 1990·The Journal of General Virology·M O McClureR A Weiss
Jan 1, 1987·Cancer Metastasis Reviews·T J McMillan, I R Hart
Dec 15, 1994·Biochemical and Biophysical Research Communications·P Seth
Jan 1, 1993·Methods in Enzymology·Y Okada
Jul 1, 1996·General Pharmacology·L M MirS Orlowski
Jun 23, 1999·Molecular Medicine Today·Y KanedaR Morishita
Mar 4, 2000·Advanced Drug Delivery Reviews·R WattiauxM Jadot
Jun 22, 2002·Journal of Drug Targeting·Hossein HosseinkhaniYasuhiko Tabata
Aug 6, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yasufumi KanedaHitoshi Kotani
Oct 5, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hossein HosseinkhaniYasuhiko Tabata
Mar 12, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hossein HosseinkhaniYasuhiko Tabata
Jun 18, 2003·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Fumihiko FujitaShigeru Katamine
Jul 8, 2003·International Journal of Cancer. Journal International Du Cancer·Stefano ButtiglieriLina Matera
Mar 20, 2004·Science·Theresa M Allen, Pieter R Cullis
Mar 23, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tomoki ItoShirou Fukuhara
Jul 13, 2004·Science·Ralph M Steinman, Ira Mellman
Jul 13, 2004·Science·Joseph N Blattman, Philip D Greenberg
Aug 5, 2004·Journal of the National Cancer Institute·Roy E SmithNorman Wolmark
Nov 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Carolina B LópezThomas M Moran
Feb 16, 2005·The Journal of Gene Medicine·Hidetoshi MimaYasufumi Kaneda
Apr 15, 2005·Molecular Immunology·Andrew G Bowie, Ismar R Haga

❮ Previous
Next ❯

Citations

Jul 27, 2007·Cancer Chemotherapy and Pharmacology·Hirokazu KawanoYasufumi Kaneda
Dec 10, 2009·Pharmaceutical Research·Paul E LundChava Kimchi-Sarfaty
Nov 28, 2007·Uirusu·Masayuki Kurooka, Yasufumi Kaneda
Mar 19, 2014·Photodiagnosis and Photodynamic Therapy·Masaya YamauchiKunio Awazu
Feb 6, 2008·Expert Opinion on Drug Delivery·Yasufumi Kaneda
Mar 5, 2013·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·María L Gil-CardezaLiliana M E Finocchiaro
Jan 22, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Joohee JungShun'ichi Kuroda
Jun 19, 2012·Biochemical and Biophysical Research Communications·Hui-fang HaoYoshio Naomoto
Oct 27, 2007·Biochemical and Biophysical Research Communications·Takashi ShimboYasufumi Kaneda
Mar 26, 2011·Clinical & Developmental Immunology·Masaji OkadaMitsunori Sakatani
Oct 25, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Chiara FondelloLiliana M E Finocchiaro
Dec 15, 2016·Human Vaccines & Immunotherapeutics·Masaji OkadaYasuko Takami
Mar 9, 2010·Bioconjugate Chemistry·Shubiao ZhangBing Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Molecular Therapy : the Journal of the American Society of Gene Therapy
Yasufumi KanedaHitoshi Kotani
Biochemical and Biophysical Research Communications
Takashi ShimboYasufumi Kaneda
Biochemical and Biophysical Research Communications
Qingxian ZhangYanling Zhang
© 2022 Meta ULC. All rights reserved